Thermo Fisher Scientific Ranks 63rd in Trading Volume with 10.88 Billion as it Expands US Manufacturing

On July 11, 2025, Thermo's trading volume reached 10.88 billion, ranking 63rd in the day's stock market. Thermo, also known as Thermo Fisher Scientific, saw a 0.96% increase, marking its second consecutive day of gains, with a total increase of 3.57% over the past two days.

Thermo Fisher Scientific has announced a significant expansion of its manufacturing capabilities in the United States. The company plans to invest $100 million in a new facility in Massachusetts, which will focus on producing advanced diagnostic tools and life science reagents. This investment is part of Thermo Fisher's broader strategy to enhance its domestic production capacity and reduce reliance on overseas suppliers.

In addition to the new facility, Thermo Fisher has also unveiled plans to upgrade its existing manufacturing sites across the country. These upgrades will include the installation of state-of-the-art equipment and the implementation of advanced automation technologies. The company aims to increase production efficiency and ensure a steady supply of critical medical and scientific products.

Thermo Fisher's expansion efforts are driven by the growing demand for diagnostic tools and life science reagents, particularly in the wake of the COVID-19 pandemic. The company's investments in domestic manufacturing are expected to strengthen its position in the market and support the broader healthcare and scientific research sectors.